Controls (n = 24) | CSFP ExECG (−) (n = 24) | CSFP ExECG (+) (n = 6) | P-value | |
---|---|---|---|---|
LV end-diastolic volume (ml) | ||||
Baseline | 85.44 ± 17.27 | 76.23 ± 16.66 | 76.90 ± 14.58 | 0.13 |
Exercise | 83.87 ± 17.35 | 73.96 ± 19.47 | 77.06 ± 15.67 | 0.22 |
Recovery | 84.34 ± 16.61 | 76.42 ± 16.87 | 77.29 ± 15.54 | 0.10 |
P-value | 0.84 | 0.82 | 0.96 | |
LV ejection fraction (%) | ||||
Baseline | 63.67 ± 2.37 | 63.00 ± 4.00 | 65.16 ± 3.39 | 0.11 |
Exercise | 68.00 ± 2.89* | 68.50 ± 3.29* | 67.35 ± 2.24 | 0.37 |
Recovery | 64.00 ± 3.31# | 63.46 ± 3.88# | 65.00 ± 2.75 | 0.30 |
P-value | < 0.001 | < 0.001 | 0.09 | |
LV GLS (%) | ||||
Baseline | −21.30 ± 2.37 | −19.77 ± 2.43 | −19.50 ± 1.13 | 0.05 |
Exercise | −23.18 ± 2.46* | −23.85 ± 2.77* | −17.29 ± 1.76* | < 0.001 |
Recovery | −21.00 ± 1.94# | −19.17 ± 2.52# | −16.84 ± 1.40* | < 0.001 |
P-value | < 0.001 | < 0.001 | 0.02 | |
LA volume index (ml/m2) | ||||
Baseline | 29.24 ± 7.33 | 31.08 ± 5.69 | 31.53 ± 6.56 | 0.73 |
Exercise | 28.72 ± 7.58 | 30.48 ± 6.21 | 31.83 ± 6.11 | 0.51 |
Recovery | 29.05 ± 7.21 | 30.91 ± 6.28 | 31.55 ± 6.00 | 0.69 |
P-value | 0.63 | 0.70 | 0.65 | |
Mitral E (cm/s) | ||||
Baseline | 72.42 ± 16.79 | 72.58 ± 18.10 | 58.67 ± 8.96 | 0.17 |
Exercise | 95.83 ± 17.40* | 92.08 ± 30.27* | 94.00 ± 10.32* | 0.86 |
Recovery | 73.83 ± 14.65# | 65.33 ± 15.52*# | 62.67 ± 8.50# | 0.08 |
P-value | < 0.001 | < 0.001 | < 0.001 | |
Mitral average e’ (cm/s) | ||||
Baseline | 8.33 ± 1.93 | 7.33 ± 1.63 | 7.00 ± 0.89 | 0.08 |
Exercise | 11.75 ± 2.67* | 10.36 ± 2.19* | 9.67 ± 0.52* | 0.06 |
Recovery | 8.00 ± 1.77# | 7.92 ± 1.64# | 8.33 ± 0.52# | 0.85 |
P-value | < 0.001 | < 0.001 | 0.002 | |
Mitral average E/e’ | ||||
Baseline | 9.08 ± 2.65 | 8.09 ± 0.87 | 7.80 ± 2.90 | 0.18 |
Exercise | 8.52 ± 2.11 | 8.70 ± 2.91 | 9.79 ± 1.60* | 0.52 |
Recovery | 9.45 ± 1.83 | 8.53 ± 2.38 | 7.54 ± 1.14# | 0.09 |
P-value | 0.31 | 0.37 | 0.02 |